Lubris Bio Pty Ltd

This study tested a new eye drop (rhPRG4) for people with moderate to severe dry eye caused by graft-versus-host disease (GVHD), a complication of bone marrow or stem cell transplants. The goal was to see if the drops were safe and could relieve dryness and eye damage. Only 3 adu…

This study tested a new eye drop (rhPRG4) to see if it safely relieves dry eye symptoms in people with Sjögren's syndrome. Only 8 adults took part in a single-day crossover design, comparing the new drop to a placebo. The trial was terminated early, so results are limited.